Emerging Growth Equities, Ltd. Initiates Coverage of Sarepta Therapeutics, Inc. (SRPT) With a BUY Rating and $38.00 Price Target |
| March 11, 2013 | March 2013 Bond Updates |
|
KING OF PRUSSIA, Pa., March 11, 2013 /PRNewswire/ -- Emerging Growth Equities, Ltd. initiates coverage of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) with a BUY rating and a $38.00 price target. Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based... |
| View more at: http://www.prnewswire.com/news-releases/emerging-growth-equities-ltd-initiates-coverage-of-sarepta-therapeutics-inc-srpt-with-a-buy-rating-and-3800-price-target-197002231.html |
| Related News |
|